Lv39
280 积分 2024-02-19 加入
Development of Toll-like Receptor Agonist-Loaded Nanoparticles as Precision Immunotherapy for Reprogramming Tumor-Associated Macrophages
20天前
已完结
PLGA and cancer: a comprehensive patent-based review on the present state of art
28天前
已完结
Combined anti-PD-1, HDAC inhibitor and anti-VEGF for MSS/pMMR colorectal cancer: a randomized phase 2 trial
10个月前
已完结
Hopes and failures in front-line advanced HER2-positive gastric cancer therapy
11个月前
已完结
HER2 testing in gastric cancer: An update
11个月前
已完结
Recent advances in biosensor devices for HER-2 cancer biomarker detection
11个月前
已完结
Targeting HER 2 and angiogenesis in gastric cancer
11个月前
已完结
The influence of tumor-induced immune dysfunction on the immune cell distribution of gold nanoparticles in vivo
1年前
已完结
皖公网安备34019202002308
